CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q2 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,439,400 | -29.6% | 26,567 | -8.9% | 0.00% | -20.0% |
Q1 2024 | $2,044,898 | +2.7% | 29,167 | +22.3% | 0.01% | -16.7% |
Q4 2023 | $1,991,570 | +229.6% | 23,854 | +16.3% | 0.01% | +200.0% |
Q3 2023 | $604,283 | -10.9% | 20,512 | -1.4% | 0.00% | 0.0% |
Q2 2023 | $678,464 | +2.5% | 20,799 | +10.6% | 0.00% | 0.0% |
Q1 2023 | $661,783 | -31.7% | 18,806 | -11.1% | 0.00% | -33.3% |
Q4 2022 | $969,047 | +2.3% | 21,149 | +8.3% | 0.00% | -25.0% |
Q3 2022 | $947,000 | +31.3% | 19,534 | +6.5% | 0.00% | +100.0% |
Q2 2022 | $721,000 | -26.4% | 18,342 | -31.0% | 0.00% | 0.0% |
Q1 2022 | $979,000 | -32.4% | 26,574 | -16.3% | 0.00% | -33.3% |
Q4 2021 | $1,448,000 | +34.3% | 31,762 | +5.3% | 0.00% | 0.0% |
Q3 2021 | $1,078,000 | +67.7% | 30,161 | -7.2% | 0.00% | +50.0% |
Q2 2021 | $643,000 | -6.9% | 32,508 | +9.5% | 0.00% | 0.0% |
Q1 2021 | $691,000 | +23.2% | 29,693 | +10.1% | 0.00% | 0.0% |
Q4 2020 | $561,000 | +24.7% | 26,978 | +29.9% | 0.00% | 0.0% |
Q3 2020 | $450,000 | +5.4% | 20,766 | +14.7% | 0.00% | 0.0% |
Q2 2020 | $427,000 | +192.5% | 18,107 | +46.6% | 0.00% | +100.0% |
Q1 2020 | $146,000 | -37.3% | 12,350 | -43.7% | 0.00% | 0.0% |
Q4 2019 | $233,000 | -13.7% | 21,947 | -7.4% | 0.00% | -50.0% |
Q3 2019 | $270,000 | +2.7% | 23,710 | +1.4% | 0.00% | 0.0% |
Q2 2019 | $263,000 | +28.9% | 23,393 | -7.0% | 0.00% | +100.0% |
Q1 2019 | $204,000 | +29.9% | 25,162 | +1.0% | 0.00% | 0.0% |
Q4 2018 | $157,000 | -45.5% | 24,919 | -14.9% | 0.00% | -50.0% |
Q3 2018 | $288,000 | +13.8% | 29,281 | -3.9% | 0.00% | 0.0% |
Q2 2018 | $253,000 | +10.5% | 30,478 | -4.1% | 0.00% | +100.0% |
Q1 2018 | $229,000 | -23.4% | 31,794 | -13.5% | 0.00% | -50.0% |
Q4 2017 | $299,000 | -39.5% | 36,735 | +7.8% | 0.00% | -60.0% |
Q3 2017 | $494,000 | +48.3% | 34,065 | +23.9% | 0.01% | +66.7% |
Q2 2017 | $333,000 | +1.2% | 27,501 | +7.5% | 0.00% | 0.0% |
Q1 2017 | $329,000 | -15.9% | 25,575 | -20.6% | 0.00% | -25.0% |
Q4 2016 | $391,000 | +714.6% | 32,207 | +137.1% | 0.00% | +300.0% |
Q3 2014 | $48,000 | -40.0% | 13,582 | -18.4% | 0.00% | 0.0% |
Q2 2014 | $80,000 | -73.0% | 16,654 | -46.5% | 0.00% | -75.0% |
Q1 2014 | $296,000 | +131.2% | 31,107 | +84.7% | 0.00% | +33.3% |
Q3 2013 | $128,000 | – | 16,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |